Skip navigation

News and updates from today's Controlled Drugs conference

Chaired by Karen O'Brien Controlled Drug Accountable Officer NHS England, North (Lancashire and Greater Manchester) and Controlled Drugs Accountable Officer Greater Manchester Health & Social Care Partnership, this conference focuses on the safe use, prescribing and management of controlled drugs including implementing the 2016 NICE guidance on the safe use and management of controlled drugs.

Dr Tessa Lewis Chair, Guideline Committee Controlled drugs: safe use and management NICE General Practitioner & Medical Adviser in Therapeutics opens the conference with an update on 'Controlled Drugs: Implementing the NEW NICE Guidance on Safe Use and Management'.  Her presentation covers:

• the NICE recommendations
• current issues and moving forward

Read the Nice Guidance on Controlled Drugs here

Pre conference abstract: 

The NICE guideline covers systems and processes for using and managing controlled drugs safely in most NHS settings. It aims to improve working practices to comply with legislation, support robust governance arrangements and reduce the safety risks associated with controlled drugs. The guideline is of relevance to a wide audience including health professionals, social care practitioners, commissioners, service providers and people being treated with controlled drugs, their families or carers. The presentation provides an overview of the guidance, uses a case example to highlight specific recommendations and considers some of the challenges for people ‘on the front-line’, particularly in primary care. 

Dr Lewis' biography:

Tessa is a GP partner and has been involved in the safe and effective use of medicines for the last 15 years. She has been locality GP prescribing lead, medical advisor to All Wales Therapeutics and Toxicology Centre and Chair of the All Wales Prescribing Advisory Group. Recent areas of interest include the safe use and management of controlled drugs, anticoagulation, antimicrobial stewardship and polypharmacy.

Current member of NICE Quality Standards Advisory Committee, Indicators Advisory Committee, Clinical Guidelines Update Committee A (Chair) and Management of Common infections (Chair).

Tessa Lewis' full powerpoint presentation 

The morning continues with a presentation from Sarah Dennison National Controlled Drugs Manager Care Quality Commission who focuses on 'Overseeing the safer management of controlled drugs', including:

• assessing and overseeing how health and social care providers manage controlled drugs
• self assessment
• maintaining a safe environment for managing controlled drugs

Pre conference abstract:

CQC have responsibilities for oversight of the implementation of The Controlled Drugs (Supervision and Management of Use) Regulations 2013 across England. This follows on from the strengthened governance arrangements put in place for controlled drugs following the Shipman enquiry. CQC’s national controlled drug responsibilities include maintaining and publishing a register of all CD accountable officers across England, attending NHS England led controlled drug local intelligence networks, chairing a national group and associated sub-groups of regulators and agencies with a controlled drug remit and working collaboratively with cross border colleagues. CQC’s controlled drug’s team report on their findings in an annual report to government and the report is published on the CQC website.

CQC are the regulator of health and care services across England and inspect and rate services by focussing on five questions, is the service: safe, effective, caring, responsive, is it well -led?

Arrangements for controlled drugs within a service are assessed along with arrangements for all other medicines as part of CQC’s inspection processes. When we inspect services, we expect the arrangements in place for controlled drugs to cover all aspects of the controlled drug journey i.e. ordering and receipt, safe storage, record keeping, prescribing, clinical use, destruction and so on. The arrangements must include how to investigate and report concerns and should include auditing and monitoring. The arrangements should take account of current national guidance, such as the NICE guidance, NHS Improvement safety alerts and so on and be regularly reviewed to reflect developments.

To support organisations’ controlled drug arrangements, controlled drug self-assessment tools for both primary and secondary care organisations and the newsletters produced by the sub groups are published on the CD pages of the CQC website.

Sarah's Biography:

Sarah qualified as a pharmacist in the mid-1980s, and worked in hospital pharmacy in both the NHS and independent sector and oversees before coming into regulation in 2003. Sarah joined CQC’s controlled drugs team, responsible for delivering CQC’s controlled drug responsibilities in 2010 and has held the post of national controlled drugs manager since 2012. 

Sarah Dennison's full powerpoint presentation

We will running this event on Thursday 11 May 2017 at The Studio Conference Centre, Birmingham contact us for information 

 


16 January 2017

 PreviousNext 

    Partner Organisations

    The Tavistock and Portman NHS Foundation TrustInPracticeClinical Audit Support CentrePlayoutJust For Nurses
    GGI (Good Governance Institute) accredited conferences CPD Member ASGBI (Association of Surgeons of Great Britain and Ireland) professional partner BADS (British Association of Day Surgery) accredited conferences